Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Taylor

Showing results (221-230 of 244) with videos related to

Pageof 25
Sort By:
Nature Communications|January 15, 2025
Long-term memory plasticity in a decade-long connectivity study post anterior temporal lobe resectionMarine N Fleury, Lawrence P Binding, Peter Taylor, et al.
Annals of the Rheumatic Diseases|June 9, 2016
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trialJose M Álvaro-Gracia, Juan A Jover, Rosario García-Vicuña, et al.
The Journal of Clinical Endocrinology and Metabolism|March 27, 2023
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED TrialPeter Taylor, Rathie Rajendram, Stephanie Hanna, et al.
Lancet (London, England)|May 21, 2016
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trialDuncan Porter, Jurgen van Melckebeke, James Dale, et al.
The Journal of Rheumatology|October 17, 2009
Reevaluation of the role of duration of morning stiffness in the assessment of rheumatoid arthritis activityNasim A Khan, Yusuf Yazici, Jaime Calvo-Alen, et al.
Annals of the Rheumatic Diseases|April 7, 2007
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countriesTuulikki Sokka, Hannu Kautiainen, Sergio Toloza, et al.
Diabetes|November 14, 2025
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 DiabetesAlfonso Galderisi, Alice L J Carr, Peter Taylor, et al.
Rheumatology (Oxford, England)|January 29, 2009
British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years)Raashid Luqmani, Sheena Hennell, Cristina Estrach, et al.
The Journal of Allergy and Clinical Immunology|November 28, 2015
RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel diseaseJelle de Wit, M Hussein Al-Mossawi, Michael H Hühn, et al.
Nature Medicine|July 30, 2024
Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trialDanijela Tatovic, Ashish Marwaha, Peter Taylor, et al.
Pageof 25

Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
Nature Communications|January 15, 2025
Long-term memory plasticity in a decade-long connectivity study post anterior temporal lobe resectionMarine N Fleury, Lawrence P Binding, Peter Taylor, et al.
Annals of the Rheumatic Diseases|June 9, 2016
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trialJose M Álvaro-Gracia, Juan A Jover, Rosario García-Vicuña, et al.
The Journal of Clinical Endocrinology and Metabolism|March 27, 2023
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED TrialPeter Taylor, Rathie Rajendram, Stephanie Hanna, et al.
Lancet (London, England)|May 21, 2016
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trialDuncan Porter, Jurgen van Melckebeke, James Dale, et al.
The Journal of Rheumatology|October 17, 2009
Reevaluation of the role of duration of morning stiffness in the assessment of rheumatoid arthritis activityNasim A Khan, Yusuf Yazici, Jaime Calvo-Alen, et al.
Annals of the Rheumatic Diseases|April 7, 2007
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countriesTuulikki Sokka, Hannu Kautiainen, Sergio Toloza, et al.
Diabetes|November 14, 2025
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 DiabetesAlfonso Galderisi, Alice L J Carr, Peter Taylor, et al.
Rheumatology (Oxford, England)|January 29, 2009
British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years)Raashid Luqmani, Sheena Hennell, Cristina Estrach, et al.
The Journal of Allergy and Clinical Immunology|November 28, 2015
RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel diseaseJelle de Wit, M Hussein Al-Mossawi, Michael H Hühn, et al.
Nature Medicine|July 30, 2024
Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trialDanijela Tatovic, Ashish Marwaha, Peter Taylor, et al.
Pageof 25